Lincoln’s YTD Global Healthcare M&A Activity Heralds Record 2019 for the Group

PE Investors Continue to Favor Healthcare for its Non-Cyclical Nature; Strategic Consolidations Continue across the entire Ecosystem

Lincoln International’s Global Healthcare mergers and acquisitions (M&A) activity in 2019 will eclipse that of 2018 led by the firm’s increasing capabilities and strong deal appetites in the sector. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and technology continues to strengthen. Lincoln is one of the only middle market investment banks with dedicated, senior healthcare bankers covering markets across North America, Europe, Asia and South America.

YTD 2019, there has been strong interest from both strategic consolidators and private equity investors, driving premium valuations for our clients’ businesses. Private equity investors continue to be aggressive bidders in processes given both the accommodating credit markets and the record levels of equity overhang globally. Lincoln’s Middle Market Index sees healthcare industry valuations up 11.5% year-over-year in Q2 2019.

Looking ahead, we foresee a continuation of the favorable structural fundamentals that have been fueling worldwide healthcare M&A volume and valuations. The forces that create healthcare opportunities are largely independent from broader macroeconomic risks of trade wars, geopolitics, and central bank interest rate policies. Both our on-going dialogues with CEOs and PE executives coupled with a strong and growing pipeline of engaged sell side mandates, further supports our bullish outlook.

We look forward to connecting with you to discuss opportunities in the sector.